Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Eye drops tested to halt worsening vision in kids

NCT ID NCT07329777

Summary

This study is testing whether low-dose atropine eye drops can safely slow down the progression of nearsightedness in children. Researchers will compare the drops to a placebo in 144 children aged 5 to 10 over two years. The goal is to find a treatment that can help control worsening vision and reduce the risk of future eye problems.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA PROGRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Pakar Kanak-Kanak UKM

    RECRUITING

    Kuala Lumpur, Cheras, 56000, Malaysia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Universiti Malaya Medical Centre

    RECRUITING

    Kuala Lumpur, Petaling Jaya, 50603, Malaysia

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.